(Date:11/24/2009)..., HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Nasd...communicationssystemsandservicesforthecommercial,i...tscommercialbusinessgrouphasbeenawardedacontractfr...rtheLevel4bio-safetylab(BSL-4)replacementfacilitya...seases(USAMRIID)atFortDetrickinFrederick,Md. ,,...
(Date:11/24/2009)..., CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-F...acquiringtheassetsofHylandSeeds,adivisionofThompso...dswillfurtherexpandDowAgroSciences,currentseedsbus...tStax(TM) in 2010 andDowAgroSciencesHerbicideTol...loseisexpectedinthenearfuture. ,, "Thisacquisit...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-FirstC...uncedtheapprovalofallofits,"firstday"motionsbytheU...nkruptcyCourt").deCODElastweekfiledavoluntarypetit...ptcyCodewiththe,BankruptcyCourt. , Theordersi...,tooperateitsbusinessduringtheChapter11proceedings...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCo...evelopmentAuthority(OPDA)wererecentlyawarded$2mill...ionBoard(CERB)inaprivate/publicpartnershiptoconstr...nLincolnCounty,WA. ,, "Thisinvestmentwillsignif...over70greenjobstoLincolnCounty,"saidBlueMarbleEner...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2...an. 28 Arno Therapeutics, Inc., a,privately held ...tered into,worldwide, exclusive license agreements...ghts to commercially develop novel, orally availab...e license agreements, Arno acquired the rights to ...r, including OSU-03012 (NSC,D728209) and OSU-HDAC4...
...ngs biotech and large pharma experience to lead ... R&D company, BALTIMORE, Jan. 28 Profectus BioSc... preventative and therapeutic,technologies to redu...today,announced that its board of directors has ap...sident and chief executive officer. O,Brien will a...
... Neuroprotective Effect in Preclinical Model of ...ISSAUGA, ON, Jan. 28 /PRNewswire-FirstCall/ - Vaso... company engaged in the research and,commercial de...ructive,inflammatory process associated with the d...eurodegenerative disorders, today announced the,pu...
Other Biology Technology:Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 2Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 3Profectus BioSciences Inc. Names Shawn Patrick O'Brien CEO 2Profectus BioSciences Inc. Names Shawn Patrick O'Brien CEO 3Vasogen's Research Published in European Journal of Neuroscience 2Vasogen's Research Published in European Journal of Neuroscience 3Vasogen's Research Published in European Journal of Neuroscience 4Vasogen's Research Published in European Journal of Neuroscience 5Mouse Anti-Human ENTPD5 Monoclonal Antibody, Unconjugated, Clone 4A5 from Abnova Corporation
Mouse Anti-Human CHD8 Monoclonal Antibody, Unconjugated, Clone 2C8 from Abnova Corporation
Mouse Anti-Human SYT4 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human SNAPC5 Monoclonal Antibody, Unconjugated, Clone 6G10 from Abnova Corporation
Biology Products: